Picton Mahoney Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Hold |
9
| – | – | ﹤0.01% | 841 |
|
|
2025
Q1 | $1K | Hold |
9
| – | – | ﹤0.01% | 803 |
|
|
2024
Q4 | $1K | Hold |
9
| – | – | ﹤0.01% | 713 |
|
|
2024
Q3 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 709 |
|
|
2021
Q4 | – | Sell |
-8,495
| Closed | -$816K | – | 969 |
|
|
2021
Q3 | $816K | Sell |
8,495
-950
| -10% | -$91.3K | 0.03% | 558 |
|
|
2021
Q2 | $920K | Buy |
+9,445
| New | +$920K | 0.03% | 560 |
|